Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Metformin × Other × Clear all

Phase

Status

Completed 10 Unknown 4 Recruiting 3 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 9 Gastrointestinal 8 Thoracic 6 Breast 4 Lymphoid 3 Head & Neck 3 Sarcoma 2 Other hematologic neoplasm 2 CNS 2 Tumor-Agnostic 1 Other 1

Conditions

Polycystic Ovary Syndrome 1 Obesity 1

Interventions

tegaserod 3 naloxegol 3 Radiotherapy 2 Radiation 2 Lidocaine 2 Cisplatin 2 prucalopride 1 pegfilgrastim 1 oxycodone naloxone combination 1 indole-3-carbinol 1 hydrated silica gel-based toothpaste 1 alvimopan 1 aluminum hydroxide, magnesium hydroxide, drug combination 1 Vitamin D 1 Thyrotropin-Releasing Hormone 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Sennosides 1 Selenomethionine 1 Phenolphthalein 1 Observation 1 Nutrition Assessment 1 Methods 1 Metformin 1 Magnesium 1 Ketamine 1 Hematologic Tests 1 Granulocyte Colony-Stimulating Factor 1 Fluorouracil 1 Filgrastim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02521753 2025-04-01

OMgObPCOS

Coordinación de Investigación en Salud, Mexico

Phase NA Terminated

Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡